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Bleeding is a clinical characteristic of severe dengue and may be due to increased vascular permeability. However, the patho-
genesis of severe dengue remains unclear. In this study, we showed that the Rac1-microfilament signal pathway was involved 
in the process of DENV serotype 2 (DENV2) infection in EAhy926 cells. DENV2 infection induced dynamic changes in actin 
organization, and treatment with Cytochalasin D or Jasplakinolide disrupted microfilament dynamics, reduced DENV2 entry, 
and inhibited DENV2 assembly and maturation. Rac1 activities decreased during the early phase and gradually increased by 
the late phase of infection. Expression of the dominant-negative form of Rac1 promoted DENV2 entry but inhibited viral as-
sembly, maturation and release. Our findings demonstrated that Rac1 plays an important role in the DENV2 life cycle by reg-
ulating actin reorganization in EAhy926 cells. This finding provides further insight into the pathogenesis of severe dengue. 
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Dengue virus (DENV) belongs to the family Flaviviridae 
and is one of the most widespread mosquito-borne human 
pathogens worldwide, especially in tropical and subtropical 
countries. Five closely related but antigenically distinct 
serotypes, DENV1–5, have been identified, including the 
previously reported serotypes DENV1–4 and the newly 
discovered serotype DENV-5, which may complicate con-
trol efforts (Normile, 2013). An estimated 390 million den-
gue infections occur each year. Therefore, DENV infection 
is an important threat to global public health (Bhatt et al., 
2013; Fang et al., 2012). However, there is currently no 
dengue vaccine and anti-viral drug available.   
DENV is the causative agent of dengue fever (DF), 
which manifests as a mild self-limiting febrile illness, i.e., 
dengue. However, the course of this illness may become 
complicated and result in the life-threatening clinical form 
of the disease, i.e., severe dengue. This condition includes 
dengue hemorrhagic fever (DHF) and dengue shock syn-
drome (DSS), which are characterized by systemic hemor-
rhage and increased capillary permeability. However, the 
mechanism underlying the increased vascular permeability 
induced by DENV infection is currently unclear. Recently, a 
morphological study identified hemorrhage, edema and 
swollen vascular endothelial cells (VECs) in several organs 
in fatal dengue patients, and viral antigens and nega-
tive-strand RNA were detected in VECs, hepatocytes and 
macrophages (Povoa et al., 2014). This finding indicated 
that increased vascular permeability and morphological 
changes of VECs are characteristic pathological features of 
severe dengue. 
The junctional complex in adjacent cells plays important 
role in maintaining the permeability of VECs. Its role is 
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attributed to a complex association of actin filaments. These 
filaments are a significant element of endothelial barrier 
function, which is regulated by linking the filaments to the 
cytoplasmic tail of junctional adhesive proteins as well as 
extracellular matrix proteins such as integrins. These com-
plexes then regulate the shape and motility of VECs. In fact, 
viruses depend on the host cellular machinery to perform 
their replication life cycle, and a number of cellular com-
ponents are involved in virus-cell interactions (Angelini et 
al., 2013; Lyman and Enquist, 2009; Monaghan et al., 
2005). Cortical actin filaments directly below the cell mem-
brane form a multifaceted network that provides aphysical 
barrier to the penetration of viruses and endocytic vesicles 
(Hanley, 2014; Pfanzagl et al., 2014; Weir et al., 2014). 
This actin network must be modulated to allow viruses to 
enter the cell and permit the consequent steps of the viral 
life cycle, especially intracellular trafficking. Thus, the actin 
cytoskeleton is one of the first components of the host cell 
to be disrupted to efficiently establish an infection with a 
diverse set of viral pathogens (Kallewaard et al., 2005; 
Sodeik et al., 1997; Stefanovic et al., 2005). Treatment with 
actin filament inhibitors reportedly affects the entry, repli-
cation and release of some viruses via the disruption of actin 
filament dynamics (Bass et al., 1995; Morrison and 
McGinnes, 1985). During West Nile virus (WNV) matura-
tion, actin filaments play a key role in viral release (Chu et 
al., 2003). Furthermore, the actin cytoskeleton plays an in-
dispensable role in influenza virus entry into epithelial cells 
(Sun and Whittaker, 2007). Our previous study has demon-
strated that DENV2 infection induced the rearrangement of 
microfilaments, and the small GTPase Rac1 played a central 
role in regulation of the actin cytoskeleton during DENV2 
infection in ECV304 cells, a mammalian cell line (Wang et al., 
2010). Moreover, we also found that DENV2 infection in-
creased the expression of β3 integrin (Zhang et al., 2007), 
which may serve as a receptor or co-receptor of DENV2 to 
mediate viral entry into human microvascular endothelial-1 
cells (HMECs-1) and ECV304 cells. The intracellular re-
gion of integrins closely associates with actin filaments, and 
the interplay of β3 integrin and DENV2 might trigger actin 
reorganization to then affect capillary endothelial integrity. 
Because ECV304 does not act as an endothelial cell line and 
the mechanisms of infection of host cells by viruses are cell 
type-dependent, the necessity of actin and Rac1 for the in-
fection of endothelium-like cells with DENV2 must be con-
firmed.  
Rac1, a member of the Rho family of GTPases is a piv-
otal component in the regulation of both actin cytoskeletal 
remodeling and the integrity of intercellular junctions 
(Bokoch et al., 1996; Edwards et al., 1999; Tolias et al., 
1995; Yang et al., 1998). In the absence of vasoactive stim-
uli, dominant-negative Rac1 affects the function of tight 
junctions and increases endothelial permeability. Specifi-
cally, Rac1 has been suggested to directly regulate these 
processes. Furthermore, Rac1 negatively regulates clathrin- 
mediated endocytosis (Lamaze et al., 1996), and some stud-
ies have shown that Rac1 is essential for viral infections 
depending on the regulation of various signal pathways. For 
example, adenovirus endocytosis requires the assembly of 
actin via the activation of phosphatidyl inositol kinase-3 
(PI3K) and Rac1 (Sanlioglu et al., 2000). Hepatitis B virus 
(HBV) infection may alter the activity of Rac1, which con-
sequently facilitates HBV replication (Tan et al., 2008). 
Murine leukemia virus can activate Rac1 in HeLa cells 
(Krishna and Le Doux, 2006). However, the role of Rac1 
activity in the regulation of VEC infection with DENV re-
mains poorly understood. 
In the present study, EAhy926 cells, an endothelium-like 
cell line, was used as a cell model to investigate the effect 
of the Rac1-microfilament pathway on DENV2 infection. 
We found that DENV2 infection not only disrupts actin 
filament dynamics but also induces dynamic changes in the 
expression of active Rac1. Treatment with actin filament 
inhibitors elicited diverse effects on various stages of the 
DENV2 life cycle, including virus entry, assembly, matura-
tion and release. These findings were recapitulated in cells 
expressing dominant-negative Rac1, suggesting that Rac1 
plays an important role in DENV2 infection by regulating 
microfilaments. Our results not only further elucidate the 
pathogenesis of severe dengue but also provide further in-
sight into the study of antiviral drugs.  
RESULTS 
Actin filament dynamics are involved in the DENV2 
life cycle 
Cyto D- or Jas-pretreated EAhy926 cells were infected with 
DENV2 to investigate the effect of actin dynamics on the 
DENV2 life cycle. The lysate was collected 1 h after infec-
tion for the detection of viral entry. Compared with 
mock-treated cells, pretreatment with Cyto D and Jas in-
duced approximately 22% and 30% decreases in viral entry 
(Figure 1A), respectively, and these decreases were signifi-
cant (P<0.05). This finding indicated that actin filament 
inhibitors inhibited virus entry and that the dynamics were 
essential for DENV2 entry into EAhy926 cells. 
Cyto D- or Jas-pretreated EAhy926 cells were infected 
with DENV2 to detect the effect of actin dynamics on 
DENV2 replication. The lysate and supernatant were col-
lected at 4 or 8 h to determine the expression of E protein 
and the intra- and extracellular viral titers. Except for the 
decrease in the E protein expression observed in Cyto 
D-and Jas-pretreated cells 4 h after infection (P<0.01 for 
CytoD-, P<0.05 for Jas-), Cyto D or Jas pretreatment did 
not affect the level of E protein at any other time point 
(Figure 1B). Moreover, Cyto D and Jas pretreatment de-
creased the intracellular titers to 66% and 65% at 4 h and to 
73% and 66% at 8 h, respectively (Figure 1C). Similarly, 
Cyto D and Jas pretreatment decreased the extracellular  
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Figure 1  The role of actin in DENV2 infection. A, The lysates of Cyto D- or Jas- pretreated EAhy926 cells were collected 1 h after DENV2 infection, and 
the entry of DENV2 was determined with a plaque assay (n=3). B, The lysates of Cyto D- or Jas- pretreated EAhy926 cells were collected at 4 and 8 h after 
DENV2 infection, and the expression levels of E protein were detected with a western blot. The densitometric analysis of E protein levels was expressed as 
ratios of drugs treated to non-drugs treated. Upper, E protein levels in Cyto D-pretreated cells and their densitometric analysis (n=3). Lower, E protein levels 
in Jas-pretreated cells and their densitometric analysis (n=3). GAPDH was used as a loading control. C and D, The lysates and supernatants of Cyto D- or 
Jas-pretreated EAhy926 cells were collected at 4 and 8 h after infection, and the intra- and extracellular viral titers were determined with a plaque assay. The 
titers in control cells (DMSO treated) were considered to be 100% (n=3). E, The ratios of the extra- to intracellular viral titer are shown as percentages. The 
data represent the mean ± SD of three independent experiments. *, P<0.05 vs. control cells. **, P<0.01 vs. control cells. 
titers to 59% and 79% at 4 hand to 68% and 73% at 8 h 
(Figure 1D), respectively. These decreases from the level of 
mock-treated cells were significant (P<0.05) and indicated 
that the actin dynamics were necessary for DENV2 replica-
tion in EAhy926 cells. Moreover, the ratios of extra- to in-
tracellular viral titers after infection in Cyto D- and 
Jas-pretreated cells were 90% and 120% at 4 h and 94% and 
110% at 8 h (Figure 1E), respectively, and did not signifi-
cantly differ from the titers of mock-treated cells. These 
results indicated that disrupting the assembly/disassembly 
actin dynamics likely did not affect viral release from 
EAhy926 cells.  
Changes in the Rac1-GTP levels after DENV2 infection 
The levels of activated Rac1 in DENV2-infected EAhy926 
cells were determined with a GST pull-down assay to inves-
tigate changes in the Rac1 activity during DENV2 infection. 
As shown in Figure 2, the levels of GTP-Rac1 (activated 
Rac1) dynamically changed during DENV2 infection: they 
markedly decreased at 20 min and 1 h and gradually re-
turned to the control levels at 4 and 8 h and then slightly 
increased at 12 and 24 h (Figure 2A, P<0.05 for 20 min and 
P<0.01 for 1 h). Moreover, activated Rac1 was observed in 
the cytoplasm 24 h after infection, primarily in the pe-
ri-nuclear area (Figure 2B), which indicated that DENV2 
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Figure 2  The changes in Rac1 activity (GTP-Rac1) after DENV2 infection, and identification of the EAhy-Rac-WT and EAhy-Rac-N17 cell lines. A, 
Upper, the activities of Rac1 (GTP-Rac1) in EAhy926 cells were detected with a western blot at the different indicated time points. GAPDH was used as a 
loading control. Lower, a densitometric analysis of the western blot results (n=3). B, The Rac1 activity (GTP-Rac1) was detected in situ with GST-CRIB 
(see Material and methods), and activated Rac1 (GTP-Rac1) was observed in the peri-nuclear area of EAhy926 cells (arrow) 24 h after DENV2 infection 
(×400). C, Upper, the expression level of Rac1 in EAhy-Rac-WT and EAhy-Rac-N17 cells was detected with a western blot. GAPDH was used as a loading 
control. Lower, a densitometric analysis of the western blot results (n=3), expressed as ratio of Rac1 levels in EAhy-Rac-N17 cell to EAhy-Rac-WT. *, 
P<0.05 vs. control cells. **, P<0.01 vs. control cells.
infection triggered endogenous Rac1 activation. 
Role of Rac1 in the DENV2 life cycle  
We established a cell line in which the expression of Rac1 
was down-regulated via the transfection of Rac1 domi-
nant-negative mutant (pRac-N17) to further analyze the 
effects of Rac1 on DENV2 infection. This cell line was 
named EAhy-Rac-N17. Simultaneously, we screened a 
wild-type Rac1 plasmid-transfected cell line, which was 
named EAhy-Rac-WT. Rac1 activity was significantly re-
duced in EAhy-Rac-N17 cells (Figure 2C), indicating that 
our cells could be used in subsequent experiments. 
EAhy-Rac-WT and EAhy-Rac-N17 cells were infected 
with DENV2 to investigate the effect of Rac1 on DENV2 
entry. The lysate was collected 1 h after infection to detect 
the levels of intracellular virus. The DENV2 titer in 
EAhy-Rac-WT cells was considered to be 100%. As shown 
in Figure 3A, the percentage of virus entry significantly 
increased to 233% in EAhy-Rac-N17 cells compared with 
EAhy-Rac-WT cells, and this increase was significant 
(P<0.01). This result indicated that Rac1 negatively regu-
lates DENV2 entry. Thus, reduced Rac1 activity was re-
quired for DENV2 entry into EAhy926 cells. 
The lysate and supernatant of DENV2-infected EAhy- 
Rac-WT and EAhy-Rac-N17 cells were collected at 4 and 8 
h after infection to investigate the effect of Rac1 on the as-
sembly and release of DENV2. The levels of E protein and 
intra- and extracellular viral titers were detected. The ex-
pression of E protein in EAhy-Rac-N17 cells did not mark-
edly change 4 and 8 h after infection compared with the 
levels in EAhy-Rac-WT cells (data not shown). Moreover, 
the intracellular titers after infection decreased to 74% and 
83% in EAhy-Rac-N17 cells at 4 and 8 h compared with the 
titers in EAhy-Rac-WT cells (Figure 3B, P<0.05 for 8 h). 
The extracellular titers in EAhy-Rac-N17 cells and de-
creased to 67% and 59% at 4 and 8 h, respectively, com-
pared with the titers in EAhy-Rac-WT cells (Figure 3C, 
P<0.01 for 8 h). The ratios of extra- to intracellular titers in 
EAhy-Rac-N17 cells were 89% and 68% at 4 h and 8 h after 
infection, respectively (Figure 3D, P<0.01 for 8 h). These 
results suggested that Rac1 activity was involved in the as-
sembly and release of DENV2. 
DISCUSSION 
Asparasitic pathogens, many viruses depend on the compo-
nents of the host cell to replicate and complete the steps of 
their life cycle, including viral entry, transportation to the 
site of replication or the release of progeny virions to the 
extracellular environment (Angelini et al., 2013; Bass et al., 
1995; Garoff et al., 1998; Kallewaard et al., 2005; Lyman 
and Enquist, 2009; Monaghan et al., 2005; Ott et al., 1996; 
Ravkov et al., 1998). A variety of viruses have been found 
to utilize diverse approaches to regulate actin cytoskeletons 
to create a suitable microenvironment for effectively estab-
lishing infection (Chu et al., 2003; Sun and Whittaker, 
2007). For example, the vaccinia virus has been shown to 
induce the formation of actin tails, and its viral particles are 
propelled on the tips of the actin tails (Frischknecht et al., 
1999). In our previous study, we have demonstrated that 
DENV2 infection induced the reorganization of actin fila- 
ments and that are regulator protein, small GTPase Rac1,  
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Figure 3  The effect of Rac1 on DENV2 infection. A, The lysates of EAhy-Rac-WT and EAhy-Rac-N17 cells were collected 1 h after infection, and the 
entry of DENV2 into the cells was determined with a plaque assay (n=3). B and C, The lysates and supernatants of EAhy-Rac-WT and EAhy-Rac-N17 cells 
were collected 4 and 8 h after infection, and the intra- and extracellular DENV2 titers were determined with a plaque assay. The titers in control cells 
(EAhy-Rac-WT) were considered to be 100% (n=3). D, The ratios of extra- to intracellular viral titer are shown as percentages. The data represent the mean 
±SD of three independent experiments. *, P<0.05 vs. control cells; **, P<0.01 vs. control cells. 
was involved in the infection of ECV304 cells with DENV2 
(Wang et al., 2010). Here, we provided evidence to further 
confirm the role of the Rac1-actin pathway in each step of 
the DENV2 replication cycle in the VEC-like cell line 
EAhy926. 
In this study, DENV2 infection could alter the actin fil-
ament dynamics in EAhy926 cells. Moreover, the disruption 
of actin filaments with Cyto D or Jas inhibited viral entry, 
assembly and maturation (i.e., decreased E protein levels 
and intracellular viral titers). The unchanged ratio of the 
extra- to intracellular viral titer observed may be due to the 
pre-treatment period (2 h), which is consistent with the 
findings in our previous study: the repressive effect of actin 
inhibitors on DENV2 release closely was associated with 
the treatment time (Wang et al., 2010). Together, these 
findings indicate that actin is involved in all steps of the 
DENV2 replication cycle. Cyto D and Jas are known to 
destabilize actin dynamics via different mechanisms: Cyto 
D inhibits the polymerization of subunit by binding to the 
plus-ends of the actin filaments, whereas Jas enhances actin 
stabilization by inhibiting the depolymerization of actin 
filaments. Under our experimental condition, the disruption 
of actin filaments with these two inhibitors elicited similar 
effects on each step of DENV2 replication cycle, indicating 
that the dynamic tread milling of actin is important for virus 
infection.  
The actin cytoskeleton is a key factor involved in the 
endocytosis and phagocytosis of several pathogens, includ-
ing viruses and bacteria. Previously, we observed that actin 
was reorganized in DENV2-infected ECV304 cells, and the 
disruption of actin cytoskeleton with interfering drugs in-
hibited DENV2 infection (Wang et al., 2010). Chu et al. 
also identified role for actin in the release of WNV (Chu et al., 
2003). In this study, viral entry, assembly and maturation 
were also repressed when actin was disrupted by treatment 
with Cyto D or Jas. Because the actin cytoskeleton plays 
active roles in endocytosis, viral intracellular transportation 
and release, treatment with Cyto D or Jas likely inhibited 
DENV2 infection.  
Rac1, a member of the Rho GTPase family, is an intrin-
sically inefficient hydrolyzing enzyme that quickly cycles 
between its GTP-bound active and GDP-bound inactive 
forms. Rac1 has been implicated in the negative regulation 
of clathrin-mediated endocytosis (Lamaze et al., 1996) and 
also plays a central role in regulating both actin cytoskeletal 
remodeling and the integrity of intercellular junctions. Re-
cent studies demonstrated that Rac1 plays important roles in 
many virus infections by regulating actin organization 
(Jimenez-Baranda et al., 2007; Li et al., 1998; Zhang et al., 
2007). For example, adenovirus endocytosis requires the 
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assembly of actin via the activation of Rac1. Integrin β3 
regulates DENV2 entry into HMEC-1 cells (Zhang et al., 
2007), and Rac1 is required for integrin-dependent cyto-
skeletal assembly (Li et al., 1998). HIV-1 Env-guided entry 
is supported by a Filamin A-RhoA-ROCK axis and Arp2/3 
complex, both of which are commonly involved in actin 
cytoskeletal reorganization (Jimenez-Baranda et al., 2007). 
In this study, DENV2 infection decreased the activities of 
Rac1 during the early phase of infection, and the role of 
Rac1 GTPase in the regulation of DENV2 infection was 
further clearly demonstrated by the increase in virus entry 
into cells expressing Rac1-N17. These results suggest that 
viral receptors may initially mediate transient Rac1 inacti-
vation in response to DENV2 binding and/or internalization, 
and Rac1 might act as a negative regulator of DENV2 entry. 
Because the Rac1 dominant-negative mutants showed a 
reduced affinity for nucleotides and cells expressing 
Rac1-N17 was similar to cells pretreated with Cyto D or 
Jas, the increase in viral entry observed may be due to the 
abrogation of downstream active Rac1 signaling, especially 
the inhibition of actin filament function. 
Interestingly Rac1 activity was gradually up-regulated 
between 4 and 24 h after DENV2 infection, and domi-
nant-negative Rac1 elicited diverse effects on DENV2 rep-
lication. Specifically, it increased viral entry during early 
infection and decreased viral replication during the late 
stages of infection, which may be due to the synergic effect 
of various signaling pathways evoked by infection, includ-
ing host anti-viral responses (Dai et al., 2011; Green et al., 
2014; Hishiki et al., 2014; Lei et al., 2013). The aforemen-
tioned synergistic effects were further demonstrated by the 
decreased levels of E protein and intracellular viral titers as 
well as the decrease in the ratios of extra- and intracellular 
viral titers observed at the same time point, indicating that 
Rac1 played an important role in the assembly, maturation 
and release of DENV2. We previously demonstrated that 
the transfection of the E gene of DENV2 could trigger the 
activation of endogenous Rac1. We also showed that the 
expression of E protein induced the reorganization of the 
actin cytoskeleton (Wang et al., 2010). These results indi-
cate that viral protein-activated Rac1 is involved in DENV2 
infection via the regulation of actin cytoskeleton reorgani-
zation. In this study, the Rac1 dominant-negative mutant 
and Cyto D or Jas treatment elicited similar effects, indicat-
ing that activated endogenous Rac1 contributes to the rear-
rangement of actin filaments during DENV infection and 
may further influence intercellular junctions and be closely 
associated with the pathogenesis of severe DF. 
In summary, we report here that the Rac1-microfilament 
pathway plays a complex role in the life cycle of DENV2 
replication. During the early phase of infection, decreased 
Rac1 activity facilitates virus entry, whereas the level of 
active Rac1 increased during the late phase of infection to 
inhibit DENV2 assembly, maturation and release. Our re-
sults suggest that Rac1 is involved in DENV2 replication 
via the regulation of actin reorganization. Overall, this study 
reveals that the Rac1-actin pathway can be co-opted by 
DENV2 to create a microenvironment that favors the estab-
lishment of successful infection. Insight into the 
DENV2-host interaction not only aids in the design of novel 
anti-viral drugs but also contributes to our understanding of 
viral pathogenesis. 
MATERIALS AND METHODS 
Cells and virus 
Aedes albopictus mosquito (C6/36) cells were grown in 
RPMI-1640 (GIBCO) containing 10% fetal bovine serum 
(FBS, GIBCO, USA). A vascular endothelial-like cell line, 
EAhy926, was grown in Dulbecco’s modified Eagle’s me-
dium (DMEM, GIBCO) containing 15% FBS. Vero cells 
were cultured in Eagle’s minimum essential medium 
(MEM, GIBCO) containing 5% FBS. 
DENV2 (strain Tr1751), which was isolated from a pa-
tient with dengue fever, was propagated in C6/36 cells and 
stored at −80°C until use. The viral titers were detected with 
plaque assay using a Vero cell monolayer in 1.2% methyl-
cellulose overlay medium. 
Antibodies and chemicals 
Mouse anti-DENV2 polyclonal antibodies (pAbs) were 
produced in our laboratory. Mouse anti-DENV2 E/NS1 
monoclonal antibodies (mAbs) were kindly provided by Dr. 
Xiaoyan Che (Zhu Jiang Hospital, Southern Medical Uni-
versity, Guangzhou, China). Rabbit anti-GAPDH pAbs 
were produced by Bioworld Technology (Nanjing). Horse-
radish peroxidase (HRP)-conjugated goat anti-mouse im-
munoglobulin (IgG) and HRP-conjugated goat anti-rabbit 
IgG were purchased from Ding Guo Chang Sheng Biotech-
nology (Beijing). FITC-conjugated goat anti-mouse IgG, 
Cy3-conjugated goat anti-mouse IgG, Cytochalasin D (Cyto 
D) and Jasplakinolide (Jas) were purchased from Sigma 
(USA). Anti-Rac1 mAb was purchased from Cytoskeleton 
(USA), and anti-GST pAbs were purchased from TransGen 
Biotech (Beijing). Lipofectamine was purchased from Invi-
trogen (USA). 
Effect of microfilament inhibitors on DENV2 infection 
Cyto D and Jas, dissolved in dimethyl sulfoxide (DMSO), were 
stored at −20°C and used at concentrations of 2 µmol L−1   
and 50 nmol L−1, respectively, as determined with 3-(4,5- 
dimethylthiazol-2-yl)-diphenyltetrazolium bromide (MTT, 
Sigma). EAhy926 cells were grown in 6-well culture plates 
and pretreated with DMEM containing 2 µmol L−1 of Cyto 
D, 50 nmol L−1 of Jas, or 0.1% of DMSO (mock- treatment, 
as control) at 37°C for 2 h. The cells were then infected 
with DENV2 (MOI=10) at 37°C for 1 h. Subsequently, the 
supernatant and/or cell lysate were collected at different 
indicated time points to determine the effect of the above 
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inhibitors on the DENV2 life cycle. 
To investigate effect of Cyto D or Jas on DENV2 entry, 
the inoculated viruses were removed 1h after infection, and 
the cells were treated with acid glycine (pH 3.0) for 2 min 
to inactivate extracellular virus. The cell lysates were then 
collected, and the viral titers were determined with plaque 
assays using Vero cells. The titer of the mock treatment 
(DMSO control) was considered to be 100%. 
To investigate the effects of CytoD or Jas on DENV2 
assembly and release, DENV2-infected cells were cultured 
in medium containing 2 µmol L−1 of CytoD or 50 nmol L−1 
of Jas, and the supernatant and lysate were collected 4 and  
8 h after infection. The E protein was detected by western 
blot, whereas extracellular and intracellular virus levels 
were detected with a plaque assay. Three independent ex-
periments were performed for each group (CytoD, Jas and 
control) and each time point. The titer of the mock treat-
ment (DMSO control) was considered to be 100%. 
Purification of GST-CRIB 
The pGEX-6p-CRIB plasmid was constructed as described 
previously (Wang et al., 2010). Briefly, the cDNA sequence 
of the CRIB domain was amplified from mouse brains and 
cloned into the pGEX-6p-1. Subsequently, Escherichia coli 
transformed with pGEX-6p-CRIB was grown in LB medi-
um containing 0.1 mg mL−1 ampicillin at 37°C for 24 h. The 
culture was then diluted 1:50 with fresh LB medium con-
taining 0.1 mg ml−1 ampicillin and incubated at 37°C for 3 
h. Thereafter, the cells were incubated with 1 mmol L−1 
IPTG (isopropyl-beta-D-thiogalactopyranoside) at 28°C for 
24 h, followed by centrifugation at 2,668×g for 10 min and 
re-suspension in phosphate buffered saline (PBS). After 
lysing the cells by sonication and centrifugation at 15,365×g 
for 20 min, the soluble fraction was incubated with gluta-
thione Sepharose 4B beads at 4°C for 24 h. The beads were 
washed three times with PBS. GST-CRIB was then har-
vested and kept at 4°C in the presence of sodium azide and 
a cocktail of protease inhibitors. 
In situ detection of Rac1 activity (Rac1-GTP) after 
DENV2 infection  
EAhy926 cells grown on coverslips were infected with 
DENV2 (MOI=10). 24 h after infection, the cells were fixed 
with 4% paraformaldehyde (in PBS) and then treated with 
0.2% Triton X-100 (in PBS) followed by incubation with 
1% bovine serum albumin (BSA in PBS) at 37°C for 30 
min. The cells were then incubated with GST-CRIB (10 μg 
mL−1) at 4°C overnight. Subsequently, the level of 
GST-CRIB was detected with an anti-GST antibody 
(1:100) and HRP-conjugated secondary antibody. 
Pull-down assay for Rac1-GTP 
GTP-Rac1 was identified by CRIB. Briefly, EAhy926 cells 
(approximately 5×106) were seeded and starved of serum 
for approximately 24 h before being infected with DENV2 
(MOI=10). At various time points after infection, the cells 
were washed twice with ice-cold PBS and lysed in 500 μL 
of lysis buffer (RIPA lysis buffer). The lysate was incubated 
with glutathione beads containing GST-CRIB for 90 min at 
4°C, and the level of Rac1-GTP was then determined by 
western blot. 
Generation of EAhy926 cells stably expressing Rac1-WT 
and Rac1-N17 
The pRe-WT and pRe-N17 plasmids, which express 
wild-type Rac1 and a dominant-negative mutant of Rac1, 
respectively, were constructed as described previously 
(Wang et al., 2010). EAhy926 cells were transfected with  
4 μg of pRe-WT or pRe-N17 using Lipofectamine 2000 
(Life Technologies, USA) according to the manufacturer’s 
instructions. 48 h after transfection, the medium was re-
placed with fresh DMEM containing 15% FBS and 0.8 mg 
mL−1 G418, and the cells were continuously cultured for 
2–3 d until the mock-treated cells died. The cells were then 
incubated with fresh DMEM containing 15% FBS and   
0.4 mg mL−1 G418 for several days to yield cells carrying 
pRe-WT or pRe-N17; these cells were named EAhy-Rac- 
WT and EAhy-Rac-N17, respectively.  
Effect of Rac1 on DENV2 infection 
EAhy-Rac-WT and EAhy-Rac-N17 were infected with 
DENV2 (MOI=10) at 37°C for 1 h. The supernatant and cell 
lysate were then collected at different time points after in-
fection to measure the protein levels and viral titers with 
western blot and plaque assays, respectively. The viral titers 
in EAhy-Rac-WT cells were considered to be 100%. Three 
independent experiments were performed for each cell line 
and each time point. 
Statistical analysis 
The statistical analyses were performed with SPSS 16.0. 
The quantitative data were compared between two groups 
using a t-test. Differences between groups were considered 
to be significant at P<0.05. 
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